aluates Reports

$ 0.0

Automative

Global Systemic Psoriasis Therapeutics Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-5G13356

Global Systemic Psoriasis Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Systemic Psoriasis Therapeutics Market Insights, Forecast to 2029

Code: QYRE-Auto-5G13356

Report

August 2023

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Systemic Psoriasis Therapeutics Market Size

The global Systemic Psoriasis Therapeutics market is projected to grow from US$ 12720 million in 2023 to US$ 19660 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

Systemic Psoriasis Therapeutics Market

Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.

Market Analysis and Insights: Global Systemic Psoriasis Therapeutics Market

One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.

Report Includes

This report presents an overview of global market for Systemic Psoriasis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Systemic Psoriasis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Systemic Psoriasis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Systemic Psoriasis Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Systemic Psoriasis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Systemic Psoriasis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie, Johnson & Johnson, Celgene, Amgen and Pfizer, etc.

Scope of Systemic Psoriasis Therapeutics Market Report

Report Metric	Details
Report Name	Systemic Psoriasis Therapeutics Market
Accounted market size in 2023	US$ 12720 million
Forecasted market size in 2029	US$ 19660 million
CAGR	7.5
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Biologics Small Molecules
Segment by Application	Mild Psoriasis Moderate Psoriasis Severe Psoriasis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Celgene, Amgen, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Systemic Psoriasis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Psoriasis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Systemic Psoriasis Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Systemic Psoriasis Therapeutics Market growing?

Ans: The Systemic Psoriasis Therapeutics Market witnessing a CAGR of 7.5 during the forecast period 2023-2029.

What is the Systemic Psoriasis Therapeutics Market size in 2029?

Ans: The global Systemic Psoriasis Therapeutics market is projected to grow from US$ 12720 million in 2023 to US$ 19660 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

Who are the main players in the Systemic Psoriasis Therapeutics Market report?

Ans: The main players in the Systemic Psoriasis Therapeutics Market are AbbVie, Johnson & Johnson, Celgene, Amgen, Pfizer

What are the Application segmentation covered in the Systemic Psoriasis Therapeutics Market report?

Ans: The Applications covered in the Systemic Psoriasis Therapeutics Market report are Mild Psoriasis, Moderate Psoriasis, Severe Psoriasis

What are the Type segmentation covered in the Systemic Psoriasis Therapeutics Market report?

Ans: The Types covered in the Systemic Psoriasis Therapeutics Market report are Biologics, Small Molecules

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Biologics

1.2.3 Small Molecules

1.3 Market by Application

1.3.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Mild Psoriasis

1.3.3 Moderate Psoriasis

1.3.4 Severe Psoriasis

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Systemic Psoriasis Therapeutics Market Perspective (2018-2029)

2.2 Global Systemic Psoriasis Therapeutics Growth Trends by Region

2.2.1 Systemic Psoriasis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Systemic Psoriasis Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Systemic Psoriasis Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Systemic Psoriasis Therapeutics Market Dynamics

2.3.1 Systemic Psoriasis Therapeutics Industry Trends

2.3.2 Systemic Psoriasis Therapeutics Market Drivers

2.3.3 Systemic Psoriasis Therapeutics Market Challenges

2.3.4 Systemic Psoriasis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Systemic Psoriasis Therapeutics by Players

3.1.1 Global Systemic Psoriasis Therapeutics Revenue by Players (2018-2023)

3.1.2 Global Systemic Psoriasis Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Systemic Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Systemic Psoriasis Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Systemic Psoriasis Therapeutics Market Concentration Ratio

3.4.1 Global Systemic Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Systemic Psoriasis Therapeutics Revenue in 2022

3.5 Global Key Players of Systemic Psoriasis Therapeutics Head office and Area Served

3.6 Global Key Players of Systemic Psoriasis Therapeutics, Product and Application

3.7 Global Key Players of Systemic Psoriasis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Systemic Psoriasis Therapeutics Breakdown Data by Type

4.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2024-2029)

5 Systemic Psoriasis Therapeutics Breakdown Data by Application

5.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Systemic Psoriasis Therapeutics Market Size (2018-2029)

6.2 North America Systemic Psoriasis Therapeutics Market Size by Type

6.2.1 North America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)

6.2.2 North America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)

6.2.3 North America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

6.3 North America Systemic Psoriasis Therapeutics Market Size by Application

6.3.1 North America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)

6.3.2 North America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)

6.3.3 North America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

6.4 North America Systemic Psoriasis Therapeutics Market Size by Country

6.4.1 North America Systemic Psoriasis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023)

6.4.3 North America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Systemic Psoriasis Therapeutics Market Size (2018-2029)

7.2 Europe Systemic Psoriasis Therapeutics Market Size by Type

7.2.1 Europe Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)

7.2.2 Europe Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)

7.2.3 Europe Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

7.3 Europe Systemic Psoriasis Therapeutics Market Size by Application

7.3.1 Europe Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)

7.3.2 Europe Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)

7.3.3 Europe Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

7.4 Europe Systemic Psoriasis Therapeutics Market Size by Country

7.4.1 Europe Systemic Psoriasis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Systemic Psoriasis Therapeutics Market Size by Country (2018-2023)

7.4.3 Europe Systemic Psoriasis Therapeutics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Systemic Psoriasis Therapeutics Market Size (2018-2029)

8.2 China Systemic Psoriasis Therapeutics Market Size by Type

8.2.1 China Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)

8.2.2 China Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)

8.2.3 China Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

8.3 China Systemic Psoriasis Therapeutics Market Size by Application

8.3.1 China Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)

8.3.2 China Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)

8.3.3 China Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Systemic Psoriasis Therapeutics Market Size (2018-2029)

9.2 Asia Systemic Psoriasis Therapeutics Market Size by Type

9.2.1 Asia Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)

9.2.2 Asia Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)

9.2.3 Asia Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

9.3 Asia Systemic Psoriasis Therapeutics Market Size by Application

9.3.1 Asia Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)

9.3.2 Asia Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)

9.3.3 Asia Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

9.4 Asia Systemic Psoriasis Therapeutics Market Size by Region

9.4.1 Asia Systemic Psoriasis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Systemic Psoriasis Therapeutics Market Size by Region (2018-2023)

9.4.3 Asia Systemic Psoriasis Therapeutics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Systemic Psoriasis Therapeutics Introduction

11.1.4 AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)

11.1.5 AbbVie Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)

11.2.5 Johnson & Johnson Recent Developments

11.3 Celgene

11.3.1 Celgene Company Details

11.3.2 Celgene Business Overview

11.3.3 Celgene Systemic Psoriasis Therapeutics Introduction

11.3.4 Celgene Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)

11.3.5 Celgene Recent Developments

11.4 Amgen

11.4.1 Amgen Company Details

11.4.2 Amgen Business Overview

11.4.3 Amgen Systemic Psoriasis Therapeutics Introduction

11.4.4 Amgen Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)

11.4.5 Amgen Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Systemic Psoriasis Therapeutics Introduction

11.5.4 Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)

11.5.5 Pfizer Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Biologics

Table 3. Key Players of Small Molecules

Table 4. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Systemic Psoriasis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Systemic Psoriasis Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Systemic Psoriasis Therapeutics Market Share by Region (2018-2023)

Table 8. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Systemic Psoriasis Therapeutics Market Share by Region (2024-2029)

Table 10. Systemic Psoriasis Therapeutics Market Trends

Table 11. Systemic Psoriasis Therapeutics Market Drivers

Table 12. Systemic Psoriasis Therapeutics Market Challenges

Table 13. Systemic Psoriasis Therapeutics Market Restraints

Table 14. Global Systemic Psoriasis Therapeutics Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Systemic Psoriasis Therapeutics Revenue Share by Players (2018-2023)

Table 16. Global Top Systemic Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Psoriasis Therapeutics as of 2022)

Table 17. Global Systemic Psoriasis Therapeutics Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Systemic Psoriasis Therapeutics Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Systemic Psoriasis Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Systemic Psoriasis Therapeutics, Product and Application

Table 21. Global Key Players of Systemic Psoriasis Therapeutics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2018-2023)

Table 25. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2024-2029)

Table 27. Global Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Systemic Psoriasis Therapeutics Revenue Share by Application (2018-2023)

Table 29. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Systemic Psoriasis Therapeutics Revenue Share by Application (2024-2029)

Table 31. North America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Systemic Psoriasis Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Systemic Psoriasis Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Systemic Psoriasis Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Systemic Psoriasis Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 63. AbbVie Company Details

Table 64. AbbVie Business Overview

Table 65. AbbVie Systemic Psoriasis Therapeutics Product

Table 66. AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)

Table 67. AbbVie Recent Developments

Table 68. Johnson & Johnson Company Details

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson Systemic Psoriasis Therapeutics Product

Table 71. Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)

Table 72. Johnson & Johnson Recent Developments

Table 73. Celgene Company Details

Table 74. Celgene Business Overview

Table 75. Celgene Systemic Psoriasis Therapeutics Product

Table 76. Celgene Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)

Table 77. Celgene Recent Developments

Table 78. Amgen Company Details

Table 79. Amgen Business Overview

Table 80. Amgen Systemic Psoriasis Therapeutics Product

Table 81. Amgen Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)

Table 82. Amgen Recent Developments

Table 83. Pfizer Company Details

Table 84. Pfizer Business Overview

Table 85. Pfizer Systemic Psoriasis Therapeutics Product

Table 86. Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)

Table 87. Pfizer Recent Developments

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Systemic Psoriasis Therapeutics Market Share by Type: 2022 VS 2029

Figure 3. Biologics Features

Figure 4. Small Molecules Features

Figure 5. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Systemic Psoriasis Therapeutics Market Share by Application: 2022 VS 2029

Figure 7. Mild Psoriasis Case Studies

Figure 8. Moderate Psoriasis Case Studies

Figure 9. Severe Psoriasis Case Studies

Figure 10. Systemic Psoriasis Therapeutics Report Years Considered

Figure 11. Global Systemic Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Systemic Psoriasis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Systemic Psoriasis Therapeutics Market Share by Region: 2022 VS 2029

Figure 14. Global Systemic Psoriasis Therapeutics Market Share by Players in 2022

Figure 15. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Psoriasis Therapeutics as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2022

Figure 17. North America Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

Figure 19. North America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

Figure 20. North America Systemic Psoriasis Therapeutics Market Share by Country (2018-2029)

Figure 21. United States Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

Figure 25. Europe Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

Figure 26. Europe Systemic Psoriasis Therapeutics Market Share by Country (2018-2029)

Figure 27. Germany Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

Figure 35. China Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

Figure 36. Asia Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

Figure 38. Asia Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

Figure 39. Asia Systemic Psoriasis Therapeutics Market Share by Region (2018-2029)

Figure 40. Japan Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Country (2018-2029)

Figure 50. Brazil Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. AbbVie Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)

Figure 57. Johnson & Johnson Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)

Figure 58. Celgene Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)

Figure 59. Amgen Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)

Figure 60. Pfizer Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Decubitus Ulcer Treatment Products Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31J5946

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cutaneous Mastocytosis Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7G6332

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Combination Treatments for Scars Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26A6047

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Dermatology Diagnostic Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36Z9309

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions